Steris Plc Asset Turnover Ratio (STE31), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Steris Plc  (NYSE: STE31)
 

Steris Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Steris Plc asset turnover ratio, the ability of Steris Plc's assets to generate revenue in the first quarter 2026, increased sequentially to 0.45 in the first quarter (Jun 30 2026), STE31's balance sheet remain strong.

Within sector 132 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from to 2716.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

STE31 Asset Turnover Ratio (Jun 30 2026)
I. Quarter		 (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Asset Change 10.38 % 74.89 % -11.28 % -8.11 % 74.4 %
Y / Y Revenue Change 23.29 % 0.58 % 0.3 % 19.42 % 38.6 %
Asset Turnover Ratio (TTM) 0.45 0.44 0.49 0.47 0.45
STE31's Total Ranking # 2716 # # # #
Seq. Asset Change 10.2 % 9.14 % -6.32 % -2.03 % 74.59 %
Seq. Revenue Change 22.76 % 1.29 % 3.81 % -4.48 % 0.14 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 133
Healthcare Sector # 326
Overall Market # 2716

Asset Turnover Ratio Statistics
High Average Low
0.57 0.44 0.14
(Mar 31 2020)   (Jun 30 2019)




STE31 Company Profile • Back to STE31 Efficiency Comparisons • Compare STE31 Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Cue Biopharma Inc   1.11 $ 37.654  Millions$ 33.860  Millions
Axsome Therapeutics Inc   1.10 $ 776.569  Millions$ 708.527  Millions
Treace Medical Concepts Inc   1.09 $ 205.307  Millions$ 188.082  Millions
Milestone Scientific Inc   1.09 $ 8.855  Millions$ 8.151  Millions
Phibro Animal Health Corporation  1.07 $ 1,516.861  Millions$ 1,423.196  Millions
Tarsus Pharmaceuticals Inc   1.06 $ 606.331  Millions$ 572.249  Millions
Arcutis Biotherapeutics Inc   1.06 $ 463.981  Millions$ 438.122  Millions
Nrc Health  1.03 $ 139.996  Millions$ 135.327  Millions
Ironwood Pharmaceuticals inc   1.03 $ 389.316  Millions$ 378.164  Millions
Alphatec Holdings Inc   1.03 $ 814.780  Millions$ 792.240  Millions
Eton Pharmaceuticals Inc   1.03 $ 105.279  Millions$ 102.535  Millions
Addus Homecare Corp  1.03 $ 1,475.610  Millions$ 1,438.108  Millions
National Vision Holdings Inc   1.02 $ 2,033.426  Millions$ 1,986.531  Millions
Tandem Diabetes Care Inc   1.02 $ 1,037.302  Millions$ 1,015.840  Millions
National Healthcare Corp  1.01 $ 1,559.020  Millions$ 1,539.896  Millions
Omada Health Inc   1.01 $ 308.445  Millions$ 305.974  Millions
Hims and Hers Health Inc   1.00 $ 2,578.494  Millions$ 2,570.967  Millions
Ensign Group Inc  1.00 $ 5,486.708  Millions$ 5,512.641  Millions
Corcept Therapeutics Inc  0.99 $ 830.813  Millions$ 840.960  Millions
Fortrea Holdings Inc   0.99 $ 2,676.500  Millions$ 2,714.025  Millions
Pacs Group Inc   0.99 $ 5,551.038  Millions$ 5,632.691  Millions
Onemednet Corporation  0.97 $ 1.590  Millions$ 1.632  Millions
Yunhong Green Cti Ltd   0.97 $ 20.662  Millions$ 21.225  Millions
Axogen inc   0.97 $ 251.174  Millions$ 258.110  Millions
Neuropace Inc   0.97 $ 98.620  Millions$ 102.177  Millions
Brightspring Health Services Inc   0.95 $ 5,877.918  Millions$ 6,165.460  Millions
Ufp Technologies Inc   0.95 $ 632.042  Millions$ 666.123  Millions
Travere Therapeutics Inc   0.95 $ 591.330  Millions$ 624.580  Millions
Vaso Corporation  0.94 $ 80.220  Millions$ 85.428  Millions
Apyx Medical Corp  0.94 $ 58.105  Millions$ 62.076  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.